David Dora

Budapest, BU 1094, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

The gut mycobiome and inter-kingdom microbial networks are linked to COPD severity in lung cancer patients.

The gut mycobiome and inter-kingdom microbial networks are linked to COPD severity in lung cancer patients.

Journal: Scientific reports

Published: October 30, 2025

Editorial: Exploring gut neuroimmunology: focus on the enteric nervous system in health and disease.

Editorial: Exploring gut neuroimmunology: focus on the enteric nervous system in health and disease.

Journal: Frontiers in neuroscience

Published: October 16, 2025

Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.

Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.

Journal: International journal of molecular sciences

Published: April 15, 2025

Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence.

Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence.

Journal: Journal of translational medicine

Published: February 04, 2025

Roles of Annexin A1 Expression in Small Cell Lung Cancer.

Roles of Annexin A1 Expression in Small Cell Lung Cancer.

Journal: Cancers

Published: January 30, 2025

Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer.

Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: December 11, 2024

Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients.

Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients.

Journal: Frontiers in immunology

Published: December 11, 2024

Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review.

Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review.

Journal: Frontiers in medicine

Published: August 29, 2024

From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

Journal: Frontiers in immunology

Published: May 18, 2024

Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer.

Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer.

Journal: Journal of translational medicine

Published: March 18, 2024

Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients.

Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients.

Journal: Frontiers in cellular and infection microbiology

Published: February 02, 2024

Resolving Resident Colonic Muscularis Macrophage Diversity and Plasticity During Colitis.

Resolving Resident Colonic Muscularis Macrophage Diversity and Plasticity During Colitis.

Journal: Inflammatory bowel diseases

Published: December 21, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026